Vnitr Lek 2017, 63(12):980-986 | DOI: 10.36290/vnl.2017.178

Unusual history of Wilson disease: a case report and review of the literature

František Nehaj1, Marianna Kubašková2, Michal Mokáň1, Juraj Sokol3,*, Vladimír Nosáľ4, Kamil Zeleňák2, Marián Mokáň1
1 I. Interná klinika JLF UK a UN Martin, Slovenská republika
2 Rádiologická klinika JLF UK a UN Martin, Slovenská republika
3 Klinika hematológie a transfuziológie, Národné centrum hemostázy a trombózy JLF UK a UN Martin, Slovenská republika
4 Neurologická klinika JLF UK a UN Martin, Slovenská republika

Wilson disease (WD) belongs to autosomal recessive genetic metabolic disorders with gene mutation ATP7B located on 13th chromosome. The enzyme ATPase plays an important role in WD. It facilitates excretion of copper into bile. This gene is responsible for modification of apoceruloplasmin. In this disease, it leads to insufficient release of copper from organism and accumulation of copper in organs such as liver, brain which can cause dysfunction of a certain organ. According to specific symptoms, we can divide WD into psychiatric, neurologic or hepatic form. The WD usually manifests between 15 and 25 years of age. Hepatic form often occurs sooner, on the contrary, the neurological variant usually occur during the later stages. We present a case report of 45-years-old woman with atypical medical history of WD, in which the diagnostic process was very long and had interdisciplinary character.

Keywords: brain; copper; diagnostic; genetics; liver; panda; Wilson disease

Received: April 16, 2017; Accepted: August 28, 2017; Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nehaj F, Kubašková M, Mokáň M, Sokol J, Nosáľ V, Zeleňák K, Mokáň M. Unusual history of Wilson disease: a case report and review of the literature. Vnitr Lek. 2017;63(12):980-986. doi: 10.36290/vnl.2017.178.
Download citation

References

  1. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47(6): 2089-2111. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.22261>. Go to original source... Go to PubMed...
  2. Mareček Z, Brůha R. Wilsonova choroba. Vnitř Lék 2013; 59(7): 578-583. Go to PubMed...
  3. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184: 173-187. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1749-6632.2009.05109.x>. Go to original source... Go to PubMed...
  4. Merle U, Schaefer M, Ferenci P et al. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007; 56(1): 115-120. Go to original source... Go to PubMed...
  5. Akil M, Brewer GJ. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol 1995; 65: 171-178.
  6. Svetel M, Potrebic A, Pekmezovic T et al. Neuropsychiatric aspects of treated Wilson's disease. Parkinsonism Relat Disord 2009; 15(10): 772-775. Dostupné z DOI<http://dx.doi.org/10.1016/j.parkreldis.2009.01.010>. Go to original source... Go to PubMed...
  7. Dušek P, Růžička E. Neurologická forma Wilsonovy nemoci. Postgraduální medicína 2011; 13(5): 472-478.
  8. Bruha R, Marecek Z, Pospisilova L et al. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int 2011; 31(1): 83-91. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1478-3231.2010.02354.x>. Go to original source... Go to PubMed...
  9. Azizi E, Eshel G, Aladjem M. Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr 1989; 148(6): 548-549. Go to original source... Go to PubMed...
  10. Menerey KA, Eider W, Brewer GJ et al. The arthropathy of Wilson's disease: clinical and pathologic features. J Rheumatol 1988; 15(2): 331-337. Go to PubMed...
  11. Saatci I, Topcu M, Baltaoglu FF et al. Cranial MR findings in Wilson's disease. Acta Radiol 1997; 38(2): 250-258. Go to original source... Go to PubMed...
  12. Holscher S, Leinweber B, Hefter H et al. Evaluation of the symptomatic treatment of residual neurological symptoms in Wilson disease. Eur Neurol 2010; 64(2): 83-87. Dostupné z DOI: <http://dx.doi.org/10.1159/000316066>. Go to original source... Go to PubMed...
  13. Weiss KH, Gotthardt DN, Klemm D et al. Zinc Monotherapy Is Not as Effective as Chelating Agents in Treatment of Wilson's Disease. Gastroenterology 2011; 140(4): 1189-1198. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2010.12.034>. Go to original source... Go to PubMed...
  14. Gromadzka G, Schmidt HH, Genschel J et al. p. H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease. Mov Disord 2006; 21(2): 245-248. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.